Benign Prostatic Hyperplasia in Taiwan
NCT00941343
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
362
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Diseases
Interventions
DRUG:
Alfuzosin (XATRAL® - SL770499)
Sponsor
Sanofi